S & Co »

Alnylam Pharmaceuticals shares owned by S & Co

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by S & Co from 13F filings

Historical chart of S & Co investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by S & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by S & Co

Quarter filed Position value Share count Share price at filing
2024-03-31 $859k 5.8k 149.39

More positions owned by S & Co

Berkshire Hathaway (BRK.B)
Church & Dwight (CHD)
Microsoft Corporation (MSFT)
Pioneer Natural Resources (PXD)
Ecolab (ECL)
Merck & Co (MRK)
Automatic Data Processing (ADP)
Apple (AAPL)
Caterpillar (CAT)
Mosaic (MOS)
Abbott Laboratories (ABT)
Johnson & Johnson (JNJ)
Alphabet Inc Class C cs (GOOG)
Cameco Corporation (CCJ)
Exxon Mobil Corporation (XOM)

View all positions for S & Co

Top funds holding Alnylam Pharmaceuticals

Vanguard Group
FMR
BlackRock
Wellington Management Company
Baillie Gifford & Co
T. Rowe Price Associates
Dodge & Cox
T. Rowe Price Investment Management
Geode Capital Management
Jpmorgan Chase & Co
American Century Companies
Susquehanna International
venBio Select Advisor
Pictet Asset Management Holding SA
Legal & General Group

View all funds holding Alnylam Pharmaceuticals